Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
J Frailty Aging ; 7(1): 47-50, 2018.
Article in English | MEDLINE | ID: mdl-29412442

ABSTRACT

The reported prevalence of sarcopenia has shown a wide range, crucially based on the diagnostic criteria and setting. This cross-sectional study evaluated the prevalence of sarcopenia and sought to identify factors associated with sarcopenia on admission in a specialized geriatric rehabilitation setting based on the newly developed the Asian Working Group for Sarcopenia algorithm. Among 87 participants (mean age, 76.05 ± 7.57 years), 35 (40.2%) were classified as showing sarcopenia on admission. Prevalence was high, particularly among participants ≥80 years old, with tendencies toward lower body mass index, smoking habit, lower cognitive function, and greater functional impairment compared with the non-sarcopenic group. Identification of sarcopenia in elderly patients before rehabilitation and consideration of risk factors may prove helpful in achieving rehabilitation outcomes.


Subject(s)
Geriatric Assessment , Hospitalization , Rehabilitation Centers , Sarcopenia/epidemiology , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Japan/epidemiology , Male , Prevalence , Risk Factors
2.
J Oral Rehabil ; 42(9): 670-7, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25892610

ABSTRACT

Although oropharyngeal and laryngeal structures are essential for swallowing, the three-dimensional (3D) anatomy is not well understood, due in part to limitations of available measuring techniques. This study uses 3D images acquired by 320-row area detector computed tomography ('320-ADCT'), to measure the pharynx and larynx and to investigate the effects of age, gender and height. Fifty-four healthy volunteers (30 male, 24 female, 23-77 years) underwent one single-phase volume scan (0.35 s) with 320-ADCT during resting tidal breathing. Six measurements of the pharynx and two of larynx were performed. Bivariate statistical methods were used to analyse the effects of gender, age and height on these measurements. Length and volume were significantly larger for men than for women for every measurement (P < 0.05) and increased with height (P < 0.05). Multiple regression analysis was performed to understand the interactions of gender, height and age. Gender, height and age each had significant effects on certain values. The volume of the larynx and hypopharynx was significantly affected by height and age. The length of pharynx was associated with gender and age. Length of the vocal folds and distance from the valleculae to the vocal folds were significantly affected by gender (P < 0.05). These results suggest that age, gender and height have independent and interacting effects on the morphology of the pharynx and larynx. Three-dimensional imaging and morphometrics using 320-ADCT are powerful tools for efficiently and reliably observing and measuring the pharynx and larynx.


Subject(s)
Aging , Body Height , Deglutition/physiology , Larynx/anatomy & histology , Multidetector Computed Tomography , Pharynx/anatomy & histology , Sex Characteristics , Adult , Aged , Epiglottis/anatomy & histology , Female , Glottis/anatomy & histology , Healthy Volunteers , Humans , Image Processing, Computer-Assisted , Larynx/diagnostic imaging , Larynx/physiology , Male , Middle Aged , Pharynx/diagnostic imaging , Pharynx/physiology , Reference Values
3.
Eur J Gynaecol Oncol ; 29(3): 252-5, 2008.
Article in English | MEDLINE | ID: mdl-18592789

ABSTRACT

PURPOSE OF INVESTIGATION: The present study was performed to identify the effects of medroxyprogesterone acetate (MPA) plus adjuvant chemotherapy on advanced epithelial ovarian carcinoma (FIGO Stage III/IV). METHODS: A total of 50 patients were enrolled in this study. A relatively low dose of MPA (200 mg/day) after surgery was administered in combination with platinum-based chemotherapy and the treatment was continued for two years. Patients' backgrounds were also analyzed. RESULTS: Relapse-free survival (p < 0.05) and overall survival (p < 0.001) rates in FIGO Stage III/IV ovarian cancer patients with MPA combined chemotherapy were significantly longer than the control group. The effect was more prominent in the higher progesterone receptor expression group. The chemotherapy regimens (cyclophosphamide, doxorubicin and cisplatin vs paraplatin plus cyclophosphamide or paclitaxel) did not affect prognosis. CONCLUSION: MPA with platinum-based chemotherapy as an adjuvant therapy might improve the prognosis in FIGO Stage III/IV epithelial ovarian cancer cases. A randomized controlled study is still needed for further analyses.


Subject(s)
Antineoplastic Agents, Hormonal/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma/drug therapy , Medroxyprogesterone Acetate/therapeutic use , Ovarian Neoplasms/drug therapy , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Carcinoma/pathology , Carcinoma/surgery , Chemotherapy, Adjuvant , Cisplatin/therapeutic use , Disease-Free Survival , Female , Follow-Up Studies , Humans , Kaplan-Meier Estimate , Medroxyprogesterone Acetate/adverse effects , Neoplasm Staging , Ovarian Neoplasms/pathology , Ovarian Neoplasms/surgery , Pilot Projects , Prognosis
4.
Eur J Gynaecol Oncol ; 28(2): 89-94, 2007.
Article in English | MEDLINE | ID: mdl-17479667

ABSTRACT

This study was performed to examine the effects of selective estrogen receptor modulators [tamoxifen (TAM) and toremifene (TOR)] and pure anti-estrogen, ICI-182780 (ICI, Faslodex) and soybean isoflavone, genistein (GE) on the expression of estrogen-stimulated c-fos/jun, ERalpha/beta and COX-1/2 in the uteri of ovarectomized mice. TAM, TOR, ICI and GE treatment significantly decreased the levels of estradiol (E2)-induced c-fos. ICI and GE treatment significantly decreased the levels of E2-induced c-jun and ERalpha expressions. High doses of TOR treatment significantly increased the E2-induced ERbeta expression. In contrast, ICI and GE treatment significantly decreased the levels of E,-induced COX-2 expression, thus suggesting that TOR and GE might prevent E2-related endometrial carcinogenesis.


Subject(s)
Cyclooxygenase Inhibitors/metabolism , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/metabolism , Genistein/pharmacology , Ovary/drug effects , Selective Estrogen Receptor Modulators/pharmacology , Animals , Dose-Response Relationship, Drug , Female , Mice , Mice, Inbred ICR , Ovarian Neoplasms/prevention & control , Ovariectomy , RNA, Messenger/metabolism , Tamoxifen/pharmacology , Toremifene/pharmacology
5.
Spinal Cord ; 45(1): 57-63, 2007 Jan.
Article in English | MEDLINE | ID: mdl-16819556

ABSTRACT

STUDY DESIGN: Retrospective study of the degree of gait independence achieved by persons with spinal cord injury (SCI) using knee-ankle-foot orthosis with a medial single hip joint (MSH-KAFO). OBJECTIVE: To examine the effects of the neurological level, degree of paresis, age, and inhibitory physical/other factors on the gait with a MSH-KAFO in patients with SCIs. SETTING: Three university hospitals and two rehabilitation hospitals in Japan. METHODS: The 45 patients (36 men, nine women) examined included 10 with injuries in the cervical cord between C6 and C8 (group C), 20 with injuries in the upper-middle thoracic cord between T4 and T10 (group UT), and 15 with injuries in the lower thoracic-lumbar cord between T12 and L1 (group TL). Mean age was 34.0 years (range 16-68 years). Of these patients, 13 used the Walkabout, four used the gear joint, and 28 used the Primewalk as the medial hip joint. Recursive partitioning, which predicted the final status of gait from the level, degree of paresis, age, and inhibitory factors, was performed, and a decision tree for gait was constructed. Inhibitory factors were spasticity, involuntary spasms or muscle contractions, pain, contracture, weakness of the upper extremities, and decreased motivation to perform gait exercise. The degree of gait independence was rated on the following five-point scale: outdoor independent gait (5 points), indoor independent gait (4 points), indoor supervised gait (3 points), indoor assisted gait (2 points), and gait within parallel bars (1 point). New branches were added to the decision tree for gait based on the clinical experience, thereby constructing a new decision tree. RESULTS: The coincident ratio between the value predicted on the basis of the decision tree of gait and the value actually observed was 53.3%. The coincident ratio between the value predicted on the basis of the modified decision tree of gait and the actually observed value was 68.9%. CONCLUSION: The results provide valuable information to medical teams that may assist prescription of gait orthoses.


Subject(s)
Decision Trees , Gait/physiology , Hip Prosthesis , Orthotic Devices , Spinal Cord Injuries/physiopathology , Spinal Cord Injuries/rehabilitation , Adolescent , Adult , Ankle Joint/physiopathology , Female , Hip Joint/physiopathology , Humans , Lower Extremity , Male , Middle Aged , Neurologic Examination , Physical Therapy Modalities , Postural Balance , Predictive Value of Tests , Retrospective Studies
6.
Eur J Gynaecol Oncol ; 28(6): 506-8, 2007.
Article in English | MEDLINE | ID: mdl-18179148

ABSTRACT

A postmenopausal 52-year-old Japanese woman with a 5-month history of a right labial tumor was referred to the Department of Obstetrics and Gynecology. The resected tumor had been diagnosed as a primary endodermal sinus tumor of the vulva with pT2N0M0 in 2001. Six courses of adjuvant chemotherapy using bleomycin, etoposide and cisplatin were administered. The patient was free of recurrence or metastasis 67 months after the initial treatment.


Subject(s)
Survivors , Vulvar Neoplasms/diagnosis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bleomycin/administration & dosage , Cisplatin/administration & dosage , Etoposide/administration & dosage , Female , Humans , Middle Aged , Vulvar Neoplasms/drug therapy
7.
Eur J Gynaecol Oncol ; 28(6): 522-3, 2007.
Article in English | MEDLINE | ID: mdl-18179154

ABSTRACT

A case of a primary uterine corpus lymphoma in a 75-year-old woman is described. Immunohistochemical studies showed diffuse large B-cell type one. Primary lymphoma of the uterine corpus is considered to be an unusual location for a common disease.


Subject(s)
Lymphoma, Non-Hodgkin/diagnosis , Uterine Neoplasms/diagnosis , Aged , Female , Humans , Lymphoma, Non-Hodgkin/diagnostic imaging , Lymphoma, Non-Hodgkin/pathology , Magnetic Resonance Imaging , Positron-Emission Tomography , Uterine Neoplasms/diagnostic imaging , Uterine Neoplasms/pathology
9.
BJOG ; 112(3): 317-20, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15713146

ABSTRACT

OBJECTIVE: To evaluate the outcome of conservative treatment of young women with endometrial cancer. DESIGN: Observational study. SETTING: Gifu University Hospital, Japan from 1988 to 2002. POPULATION: Twelve women with endometrial cancer, FIGO IA estimated by MRI under 35 years. METHODS: Patients were treated with medroxyprogestreone acetate (400-600 mg/day) for 6-10 months, with endometrial curettage performed every four weeks. MAIN OUTCOME MEASURES: Response to therapy, pregnancies and reoccurrence of disease during follow up over a 30-month period. RESULTS: All cases had pathological complete remissions within 6-10 months. Seven of 10 wishing to have babies conceived, and five of them were delivered of full-term babies. Eight of nine cases receiving long term follow up (over 30 months) developed recurrent disease, with four opting for hysterectomy. No patient developed distant metastases or had disease-related death. CONCLUSION: Conservative therapy is feasible in carefully selected young women with endometrial cancer. Recurrence rates were high during long term observation even after pathological complete remissions. Therefore, close follow up is recommended.


Subject(s)
Antineoplastic Agents, Hormonal/administration & dosage , Carcinoma/drug therapy , Endometrial Neoplasms/drug therapy , Infertility, Female/prevention & control , Medroxyprogesterone Acetate/administration & dosage , Pregnancy Complications, Neoplastic/drug therapy , Adenocarcinoma/drug therapy , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Adult , Carcinoma/pathology , Carcinoma/surgery , Carcinoma, Adenosquamous/drug therapy , Carcinoma, Adenosquamous/pathology , Carcinoma, Adenosquamous/surgery , Cohort Studies , Combined Modality Therapy/methods , Dilatation and Curettage/methods , Endometrial Neoplasms/pathology , Endometrial Neoplasms/surgery , Endometrium/pathology , Female , Follow-Up Studies , Humans , Neoplasm Recurrence, Local/etiology , Pregnancy , Pregnancy Complications, Neoplastic/pathology , Pregnancy Complications, Neoplastic/surgery , Pregnancy Outcome , Treatment Outcome
10.
Antimicrob Agents Chemother ; 44(10): 2653-8, 2000 Oct.
Article in English | MEDLINE | ID: mdl-10991839

ABSTRACT

We induced resistance to systemic Candida albicans infection through CD4(+)-cell-mediated immunity in mice by immunization with subcutaneous injections of live C. albicans cells emulsified in incomplete Freund adjuvant. Using the resistant mice, we tested subcellular fractions of C. albicans cells for antigenicity. The fractions were derived from digested surface cell walls, insoluble membranes, or soluble and insoluble cytoplasmic materials, which were prepared by treatment with cell wall-digesting enzymes followed by lysis of the consequent protoplasts. Interestingly, the live-cell-immunized mice showed strong cell-mediated immune responses to the membrane fraction (C. albicans membrane antigen [CMA]). In addition, immunization with CMA induced resistance to systemic candidiasis, which disappeared upon administration of anti-CD4 monoclonal antibody. Infusion of splenocytes from the CMA-immunized mice conferred resistance on SCID mice, whereas infusion of CD4(+)-T-cell-depleted splenocytes was unable to induce resistance, indicating the importance of CD4(+) lymphocytes for resistance. These results suggest a potential for the membrane fraction to act as an antigen conferring resistance to systemic candidiasis in place of live cells and also as a source for the isolation of a new antigen.


Subject(s)
Antigens, Fungal/immunology , CD4-Positive T-Lymphocytes/immunology , Candida albicans/immunology , Candidiasis/immunology , Adoptive Transfer , Animals , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/pharmacology , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/immunology , Cell Division/physiology , Cytokines/metabolism , Female , Hypersensitivity, Delayed/immunology , Immunity, Cellular/immunology , Immunity, Cellular/physiology , Immunization , Lymphocyte Depletion , Membranes/immunology , Mice , Mice, Inbred BALB C , Spleen/cytology , Spleen/metabolism , Subcellular Fractions/immunology
11.
Keio J Med ; 48(4): 175-8, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10638140

ABSTRACT

The "Extensor habitus" phenomenon occurs in finger flexor tendon injuries and consists of a paradoxical extension of the interphalangeal joints after an attempt to flex the finger. The mechanism of extension is considered to be a contraction of the flexor digitorum profundus that is then transmitted via the lumbrical muscle structure to the extensor expansion. Using electromyography, we recorded the lumbrical muscle activity during the paradoxical extension phenomenon to determine whether the lumbrical muscle contributed to this event. Two patterns of electromyographical activity of the lumbrical muscle were observed. Group I (6 fingers) displayed electrical activities in the lumbrical muscle during flexion tasks, while group II (12 fingers) did not. In group I, the lesions were mainly located in zone V, and the response to range of motion exercises was satisfactory. In group II, nearly all of the lesion were located in zone II, and half of the cases required additional surgical interventions. Group II appeared to exhibit the "Extensor habitus" phenomenon, while group I exhibited an "Extensor habitus-like phenomenon." To distinguish between these two phenomena, an electromyographical examination of the lumbrical muscle must be performed.


Subject(s)
Finger Injuries/physiopathology , Tendon Injuries , Adolescent , Adult , Child , Electromyography , Female , Finger Injuries/surgery , Humans , Male , Middle Aged , Muscle, Skeletal/physiopathology , Tendons/physiopathology , Tendons/surgery
12.
J Med Chem ; 40(7): 1075-89, 1997 Mar 28.
Article in English | MEDLINE | ID: mdl-9089329

ABSTRACT

The synthesis and CysLT1 antagonistic activities of a new series of 2-, 3-, and 4-(2-quinolinylmethoxy)- and 3- and 4-[2-(2-quinolinyl)ethenyl]-substituted, 2'-, 3'-, 4'-, or 5'-carboxylated chalcones are described. Structure-activity relationship studies indicate a preference for the presence of a negatively charged (acidic) moiety, although in some cases nitrile or ester analogues also exhibit moderate activity. The quinoline moiety may be substituted at either the 3- or the 4-position. Replacement of this heterocycle by other aromatic groups results in compounds with comparable affinities [2-(7-chloroquinoline), 1-(1-methyl-2-benzimidazole), or 1-(2-benzothiazole)] or substantially lower activities [1-(1-ethoxyethyl)-2-benzimidazole, 2-naphthyl, or phenyl]. The quinoline and chalcone moieties may be connected by either an ethenyl or a methoxy spacer. The acidic moiety at the chalcone B ring may be attached to the 2'-, 3'-, 4'-, or 5'-position, for both the 3- and 4-substituted chalcones. There are no general patterns to specify which substitution positions gave the most potent compounds. The series contains several potent CysLT1 receptor antagonists, with K(D) values approaching the nanomolar range, as measured by the displacement of [3H]LTD4 from guinea pig lung membranes. Antagonism of LTD4-induced contraction of guinea pig ileum, the inhibition of antigen-induced contraction of guinea pig trachea in vitro, and the inhibition of LTD4-induced increase of vascular permeability in vivo are determined for chalcones with high CysLT1 receptor affinities (K(D) values below 0.1 microM). 2'-Hydroxy-4-(2-quinolinylmethoxy)-5'-(5-tetrazolyl)chalcone (14, VUF 4819) showed good activity in both in vitro and in vivo assays and has been selected for further evaluation.


Subject(s)
Chalcone/chemical synthesis , Leukotriene Antagonists , Membrane Proteins , Receptors, Leukotriene , Animals , Chalcone/chemistry , Chalcone/pharmacology , Guinea Pigs , Ileum/drug effects , Ileum/metabolism , Ileum/physiology , In Vitro Techniques , Lung/drug effects , Lung/metabolism , Magnetic Resonance Spectroscopy , Male , Mass Spectrometry , Muscle Contraction/drug effects , Structure-Activity Relationship , Trachea/drug effects , Trachea/metabolism , Trachea/physiology
17.
Experientia ; 34(1): 92-3, 1978 Jan 15.
Article in English | MEDLINE | ID: mdl-620751

ABSTRACT

The excitation/emission spectra maxima obtained from orange fluorescing small cell clusters and greenish yellow fluorescing ganglion cell bodies were at 400--410/490--560 nm and at 400--410/470--500 nm, respectively.


Subject(s)
Catecholamines/analysis , Ganglia, Autonomic/cytology , Animals , Anura , Epinephrine/analysis , Histocytochemistry , Male , Norepinephrine/analysis , Spectrometry, Fluorescence
SELECTION OF CITATIONS
SEARCH DETAIL
...